Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
Interleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key r...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/1/109 |
_version_ | 1797342824715255808 |
---|---|
author | Miao Huang Long Wang Qianhui Zhang Ling Zhou Rui Liao Anguo Wu Xinle Wang Jiesi Luo Feihong Huang Wenjun Zou Jianming Wu |
author_facet | Miao Huang Long Wang Qianhui Zhang Ling Zhou Rui Liao Anguo Wu Xinle Wang Jiesi Luo Feihong Huang Wenjun Zou Jianming Wu |
author_sort | Miao Huang |
collection | DOAJ |
description | Interleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key regulators, exerting significant influence on the development, maturation, and activity of megakaryocytes (MKs) and platelets. While the therapeutic potential of interleukins in platelet-related diseases has been recognized for decades, their clinical application has been hindered by limitations in basic research and challenges in drug development. Recent advancements in understanding the molecular mechanisms of interleukins and their interactions with MKs and platelets, coupled with breakthroughs in cytokine engineering, have revitalized the field of interleukin-based therapeutics. These breakthroughs have paved the way for the development of more effective and specific interleukin-based therapies for the treatment of platelet disorders. This review provides a comprehensive overview of the effects of interleukins on megakaryopoiesis, thrombopoiesis, and platelet function. It highlights the potential clinical applications of interleukins in regulating megakaryopoiesis and platelet function and discusses the latest bioengineering technologies that could improve the pharmacokinetic properties of interleukins. By synthesizing the current knowledge in this field, this review aims to provide valuable insights for future research into the clinical application of interleukins in platelet-related diseases. |
first_indexed | 2024-03-08T10:38:47Z |
format | Article |
id | doaj.art-c679079971024a58aecc38e29fcddf35 |
institution | Directory Open Access Journal |
issn | 1424-8247 |
language | English |
last_indexed | 2024-03-08T10:38:47Z |
publishDate | 2024-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceuticals |
spelling | doaj.art-c679079971024a58aecc38e29fcddf352024-01-26T18:06:05ZengMDPI AGPharmaceuticals1424-82472024-01-0117110910.3390/ph17010109Interleukins in Platelet Biology: Unraveling the Complex Regulatory NetworkMiao Huang0Long Wang1Qianhui Zhang2Ling Zhou3Rui Liao4Anguo Wu5Xinle Wang6Jiesi Luo7Feihong Huang8Wenjun Zou9Jianming Wu10State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaInterleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key regulators, exerting significant influence on the development, maturation, and activity of megakaryocytes (MKs) and platelets. While the therapeutic potential of interleukins in platelet-related diseases has been recognized for decades, their clinical application has been hindered by limitations in basic research and challenges in drug development. Recent advancements in understanding the molecular mechanisms of interleukins and their interactions with MKs and platelets, coupled with breakthroughs in cytokine engineering, have revitalized the field of interleukin-based therapeutics. These breakthroughs have paved the way for the development of more effective and specific interleukin-based therapies for the treatment of platelet disorders. This review provides a comprehensive overview of the effects of interleukins on megakaryopoiesis, thrombopoiesis, and platelet function. It highlights the potential clinical applications of interleukins in regulating megakaryopoiesis and platelet function and discusses the latest bioengineering technologies that could improve the pharmacokinetic properties of interleukins. By synthesizing the current knowledge in this field, this review aims to provide valuable insights for future research into the clinical application of interleukins in platelet-related diseases.https://www.mdpi.com/1424-8247/17/1/109interleukinsmegakaryopoiesisthrombopoiesisbioengineering |
spellingShingle | Miao Huang Long Wang Qianhui Zhang Ling Zhou Rui Liao Anguo Wu Xinle Wang Jiesi Luo Feihong Huang Wenjun Zou Jianming Wu Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network Pharmaceuticals interleukins megakaryopoiesis thrombopoiesis bioengineering |
title | Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network |
title_full | Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network |
title_fullStr | Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network |
title_full_unstemmed | Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network |
title_short | Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network |
title_sort | interleukins in platelet biology unraveling the complex regulatory network |
topic | interleukins megakaryopoiesis thrombopoiesis bioengineering |
url | https://www.mdpi.com/1424-8247/17/1/109 |
work_keys_str_mv | AT miaohuang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT longwang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT qianhuizhang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT lingzhou interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT ruiliao interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT anguowu interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT xinlewang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT jiesiluo interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT feihonghuang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT wenjunzou interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork AT jianmingwu interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork |